Free Trial

Thomas David Hull III Sells 721 Shares of Kewaunee Scientific (NASDAQ:KEQU) Stock

Kewaunee Scientific logo with Computer and Technology background

Key Points

  • CEO Thomas David Hull III sold 721 shares of Kewaunee Scientific stock at an average price of $44.00, resulting in a transaction value of $31,724.00 and a 1.67% decrease in his holdings.
  • Kewaunee Scientific's stock recently traded at $43.85, with a market cap of $125.85 million and a P/E ratio of 10.62.
  • Institutional investors have significantly increased their positions, with 32.69% of the stock now owned by these entities, indicating increased confidence in the company.
  • Interested in Kewaunee Scientific? Here are five stocks we like better.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 721 shares of Kewaunee Scientific stock in a transaction dated Tuesday, September 23rd. The shares were sold at an average price of $44.00, for a total value of $31,724.00. Following the transaction, the chief executive officer owned 42,573 shares of the company's stock, valued at $1,873,212. The trade was a 1.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Thomas David Hull III also recently made the following trade(s):

  • On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.62, for a total value of $43,620.00.
  • On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.34, for a total value of $35,047.82.
  • On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total value of $29,992.00.

Kewaunee Scientific Stock Performance

Shares of NASDAQ KEQU traded up $0.37 during trading on Wednesday, reaching $43.85. 9,625 shares of the company traded hands, compared to its average volume of 17,750. The firm's fifty day simple moving average is $53.94 and its 200 day simple moving average is $45.49. The stock has a market cap of $125.85 million, a P/E ratio of 10.62 and a beta of 0.75. Kewaunee Scientific Corporation has a 12-month low of $30.33 and a 12-month high of $71.33. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The business had revenue of $71.10 million during the quarter.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE boosted its holdings in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after purchasing an additional 443 shares during the last quarter. IFP Advisors Inc lifted its holdings in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after acquiring an additional 360 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Kewaunee Scientific in the second quarter valued at approximately $60,000. Wedbush Securities Inc. purchased a new stake in Kewaunee Scientific in the second quarter valued at approximately $232,000. Finally, Morgan Dempsey Capital Management LLC increased its position in shares of Kewaunee Scientific by 41.8% during the second quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company's stock worth $247,000 after acquiring an additional 1,247 shares during the period. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th.

Get Our Latest Report on KEQU

About Kewaunee Scientific

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Further Reading

Insider Buying and Selling by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kewaunee Scientific Right Now?

Before you consider Kewaunee Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.

While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.